Platelet-Rich Plasma Therapy

Platelet-Rich Plasma (PRP) therapy is an advanced, research-based medical approach designed to support the body’s natural repair mechanisms. It uses a concentration of a patient’s own platelets - blood elements rich in growth factors - to enhance certain tissue-regeneration processes.

PRP has gained increasing attention due to its potential to improve function and relieve discomfort in musculoskeletal conditions, including joint pain, spine-related pain, tendon injuries, and degenerative disorders.

At the Spine & Pain, PRP therapy is part of a comprehensive, evidence-guided approach to managing pain and promoting healing in patients with chronic musculoskeletal conditions. The institute integrates advanced regenerative techniques with personalized treatment planning to help restore function and quality of life.

Platelet-Rich Plasma is an autologous preparation derived from a patient’s own blood. The process involves collecting a small blood sample and using a centrifugation method to separate plasma with a high concentration of platelets. These platelets release bioactive proteins which play a key role in healing.

In medicine, PRP is used to enhance tissue regeneration, stimulate collagen production, and modulate inflammation. Its application is considered minimally invasive and has been studied across multiple medical fields for its regenerative potential.

Platelet‑Rich Plasma Therapy (PRP) provides meaningful support for patients experiencing various types of musculoskeletal pain, including joint pain and spine-related pain.

By enhancing the local regenerative environment, PRP is applied in conditions where conventional treatments yield limited recovery, slower healing, or persistent discomfort. PRP is increasingly considered a complementary option in regenerative medicine.

The procedure begins with a simple blood draw, typically from the patient’s arm. The collected blood is processed in a centrifuge to concentrate the platelets. Once prepared, the platelet-rich portion is reintroduced into the targeted tissue through a localized injection.

Because PRP uses the patient’s own blood components, the risk of adverse reactions is minimal. The entire process is typically performed in an outpatient setting under sterile conditions and may take less than one hour.

Platelet-Rich Plasma (PRP) therapy has promising results in helping the body repair and regenerate damaged tissues. Its effectiveness comes from using the patient’s own platelets to deliver concentrated growth factors directly to areas of injury or degeneration, where they stimulate healing and reduce inflammation.

Patients experience gradual improvement in pain, mobility, and function within weeks of treatment. PRP can be particularly effective for chronic musculoskeletal conditions such as joint pain, spine-related pain, tendon injuries, and mild to moderate osteoarthritis. It supports natural healing processes rather than masking symptoms, offering a restorative option that fits between conservative care and surgery.

PRP therapy is considered a safe and valuable option for people seeking to restore movement, reduce pain, and return to daily activities with better comfort and flexibility. It represents a modern, regenerative approach to long-term musculoskeletal health and functional recovery.

Platelet-Rich Plasma (PRP): Science, Applications, and Clinical Overview

Bos-Mikich A, de Oliveira R, Frantz N. Platelet-rich plasma therapy and reproductive medicine. J Assist Reprod Genet. 2018 May;35(5):753-756. doi:10.1007/s10815-018-1159-8. Epub 2018 Mar 21. PMID: 29564738; PMCID: PMC5984895. Link: https://pmc.ncbi.nlm.nih.gov/articles/PMC5984895/

Gupta S., Paliczak A., Delgado D. Evidence-based indications of platelet-rich plasma therapy. Expert Review of Hematology. 2020. DOI:10.1080/17474086.2021.1860002. Link: https://www.tandfonline.com/doi/full/10.1080/17474086.2021.1860002

Fang J., Wang X., Jiang W., et al. Platelet-Rich Plasma Therapy in the Treatment of Diseases Associated with Orthopedic Injuries. Tissue Eng Part B Rev. 2020 Dec 15;26(6):571–585. Link: https://www.liebertpub.com/doi/10.1089/ten.teb.2019.0292

Kia C, Baldino J, Bell R, Ramji A, Uyeki C, Mazzocca A. Platelet-Rich Plasma: Review of Current Literature on its Use for Tendon and Ligament Pathology. Curr Rev Musculoskelet Med. 2018 Dec;11(4):566-572. doi: 10.1007/s12178-018-9515-y. PMID: 30203334; PMCID: PMC6220011. Link: https://pmc.ncbi.nlm.nih.gov/articles/PMC6220011/

Redler, Lauren H.; Thompson, Scott A.; Hsu, Stephanie H.; Ahmad, Christopher S.; Levine, William N. “Platelet-Rich Plasma Therapy: A Systematic Literature Review and Evidence for Clinical Use.” The Physician and Sportsmedicine, 2011;39(1):42-51. doi:10.3810/psm.2011.02.1861. Link: https://pubmed.ncbi.nlm.nih.gov/21378486/